Skip to main content
Fig. 3 | Journal of Inflammation

Fig. 3

From: Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice

Fig. 3

Serum TNF-α level in zymosan-treated (Z) and melanoma-bearing (M) mice. Serum TNF-α measured by ELISA was determined in control untreated mice, M, Z and zymosan-treated (10 μg, i.p.) melanoma-bearing (ZM) mice. The results are presented as means ± SD of 5 mice in each group. +P < 0.05 compared with control group, *P < 0.05 compared with M mice, #P < 0.05 compared with ZM, XP < 0.05 compared with Z mice

Back to article page